These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11395574)

  • 1. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.
    Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
    Anticancer Drugs; 2003 Oct; 14(9):767-71. PubMed ID: 14551512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.
    Mackie PS; Fisher JL; Zhou H; Choong PF
    Br J Cancer; 2001 Apr; 84(7):951-8. PubMed ID: 11286476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.
    Ashton JA; Farese JP; Milner RJ; Lee-Ambrose LM; van Gilder JM
    Am J Vet Res; 2005 May; 66(5):885-91. PubMed ID: 15934617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effects of bisphosphonates.
    Green JR
    Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.
    Shipman CM; Rogers MJ; Apperley JF; Russell RG; Croucher PI
    Br J Haematol; 1997 Sep; 98(3):665-72. PubMed ID: 9332325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates induce apoptosis in human breast cancer cell lines.
    Senaratne SG; Pirianov G; Mansi JL; Arnett TR; Colston KW
    Br J Cancer; 2000 Apr; 82(8):1459-68. PubMed ID: 10780527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates and breast carcinoma.
    Lipton A
    Cancer; 1997 Oct; 80(8 Suppl):1668-73. PubMed ID: 9362434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.
    Boissier S; Magnetto S; Frappart L; Cuzin B; Ebetino FH; Delmas PD; Clezardin P
    Cancer Res; 1997 Sep; 57(18):3890-4. PubMed ID: 9307266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.
    Jagdev SP; Purohit P; Heatley S; Herling C; Coleman RE
    Ann Oncol; 2001 Oct; 12(10):1433-8. PubMed ID: 11762816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates induce breast cancer cell death in vitro.
    Fromigue O; Lagneaux L; Body JJ
    J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro cytoreductive effects on multiple myeloma cells induced by bisphosphonates.
    Aparicio A; Gardner A; Tu Y; Savage A; Berenson J; Lichtenstein A
    Leukemia; 1998 Feb; 12(2):220-9. PubMed ID: 9519785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.
    Takahashi R; Shimazaki C; Inaba T; Okano A; Hatsuse M; Okamoto A; Hirai H; Ashihara E; Nakagawa M
    Leuk Res; 2001 Jan; 25(1):77-83. PubMed ID: 11137564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
    Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
    Boissier S; Ferreras M; Peyruchaud O; Magnetto S; Ebetino FH; Colombel M; Delmas P; Delaissé JM; Clézardin P
    Cancer Res; 2000 Jun; 60(11):2949-54. PubMed ID: 10850442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
    Mönkkönen J; Taskinen M; Auriola SO; Urtti A
    J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate therapy in multiple myeloma: past, present, future.
    Jantunen E
    Eur J Haematol; 2002; 69(5-6):257-64. PubMed ID: 12460229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.